Literature DB >> 26232697

Neuroectoderm-specific deletion of cathepsin D in mice models human inherited neuronal ceroid lipofuscinosis type 10.

Anett Ketscher1, Stephanie Ketterer2, Susanne Dollwet-Mack1, Ulrike Reif1, Thomas Reinheckel3.   

Abstract

Cathepsin D (Ctsd) is a ubiquitously expressed aspartic protease functioning primarily in the acidic endosomal/lysosomal cell compartment. At an age of 26 ± 1 days, mice with constitutive Ctsd deficiency (Ctsd(-/-)) die from a neurodegenerative lysosomal storage disease equivalent to the congenital neuronal ceroid lipofuscinosis (NCL) type 10 in humans. In addition to neurodegeneration, Ctsd(-/-) mice exhibit a loss of CD4(+)/CD8(+)-double-positive thymocytes and an atrophy of the intestinal mucosa. To date, it is not understood if and how these phenotypes are triggering each other. In addition, the cell type causing initiation of NCL in Ctsd(-/-) mice has not been identified yet. To investigate the tissue- and cell type-specific functions of Ctsd, we generated a novel conditional Ctsd allele by flanking the second exon with loxP sites. We compared a ubiquitous Ctsd deletion with a deletion of the protease by a Nestin-promoter controlled Cre-recombinase expression in cells of neuroectodermal origin, e.g. in neurons and astroglia, but not in microglia. First, we confirmed absence of Ctsd in the respective cell- and tissue types. The neuroectoderm specific knock-out mice survived about 5.5 days longer than the mice with ubiquitous Ctsd deletion, which was in line with the progress in brain histopathology. Atrophies of thymus and small intestine were delayed to similar extend. The conditional Ctsd knock-out mouse model established in this study not only demonstrates that this type of NCL is initiated by cells of neuroectodermal origin, but will also help to further study tissue-specific functions of Ctsd in vivo.
Copyright © 2015 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Cathepsin D; Conditional knock-out; Neurodegenerative disease; Neuronal lipofuscinosis

Mesh:

Substances:

Year:  2015        PMID: 26232697     DOI: 10.1016/j.biochi.2015.07.020

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

1.  Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.

Authors:  Penglong Wu; Xun Yuan; Faqian Li; Jianhua Zhang; Wei Zhu; Meng Wei; Jingbo Li; Xuejun Wang
Journal:  Circ Heart Fail       Date:  2017-07-10       Impact factor: 8.790

2.  Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.

Authors:  André R A Marques; Alessandro Di Spiezio; Niklas Thießen; Lina Schmidt; Joachim Grötzinger; Renate Lüllmann-Rauch; Markus Damme; Steffen E Storck; Claus U Pietrzik; Jens Fogh; Julia Bär; Marina Mikhaylova; Markus Glatzel; Mahmoud Bassal; Udo Bartsch; Paul Saftig
Journal:  Autophagy       Date:  2019-07-16       Impact factor: 16.016

3.  Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis.

Authors:  Ali A Aghdassi; Daniel S John; Matthias Sendler; F Ulrich Weiss; Thomas Reinheckel; Julia Mayerle; Markus M Lerch
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

4.  Lysosomal Cathepsin Protease Gene Expression Profiles in the Human Brain During Normal Development.

Authors:  Amy Hsu; Sonia Podvin; Vivian Hook
Journal:  J Mol Neurosci       Date:  2018-07-14       Impact factor: 3.444

5.  A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.

Authors:  Lindsay B Alcaraz; Aude Mallavialle; Timothée David; Danielle Derocq; Frédéric Delolme; Cindy Dieryckx; Caroline Mollevi; Florence Boissière-Michot; Joëlle Simony-Lafontaine; Stanislas Du Manoir; Pitter F Huesgen; Christopher M Overall; Sophie Tartare-Deckert; William Jacot; Thierry Chardès; Séverine Guiu; Pascal Roger; Thomas Reinheckel; Catherine Moali; Emmanuelle Liaudet-Coopman
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

6.  Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40.

Authors:  Caitlin N Suire; Samer O Abdul-Hay; Tomoko Sahara; Dongcheul Kang; Monica K Brizuela; Paul Saftig; Dennis W Dickson; Terrone L Rosenberry; Malcolm A Leissring
Journal:  Alzheimers Res Ther       Date:  2020-07-06       Impact factor: 6.982

7.  Ageing-induced changes in the redox status of peripheral motor nerves imply an effect on redox signalling rather than oxidative damage.

Authors:  Brian McDonagh; Siobhan M Scullion; Aphrodite Vasilaki; Natalie Pollock; Anne McArdle; Malcolm J Jackson
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.